Increased intestinal absorption in the era of teduglutide and its impact on management strategies in patients with short bowel syndrome-associated intestinal failure

Journal of Parenteral and Enteral Nutrition

Volumn 37, Issue 2, 2013, Pages 201-211

  Seidner, Douglas L ^a   Schwartz, Lauren K ^b   Winkler, Marion F ^c   Jeejeebhoy, Khursheed ^d   Boullata, Joseph I ^e   Tappenden, Kelly A ^f  

^a Vanderbilt Center for Human Nutrition   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

^f UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

fluid balance; GLP 2; intestinal failure; malabsorption; multidisciplinary care; parenteral nutrition; short bowel syndrome; teduglutide; treatment

Indexed keywords

ELECTROLYTE; GLUCAGON LIKE PEPTIDE 2; INFUSION FLUID; PLACEBO; TEDUGLUTIDE;

DISEASE ASSOCIATION; DRUG EFFICACY; ELECTROLYTE INTAKE; FLUID THERAPY; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINAL FAILURE; INTESTINE RESECTION; LONG TERM CARE; MALABSORPTION; NUTRITIONAL REQUIREMENT; PARENTERAL NUTRITION; PHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHORT BOWEL SYNDROME; TREATMENT CONTRAINDICATION; TREATMENT PLANNING; TREATMENT WITHDRAWAL;

ADAPTATION, PHYSIOLOGICAL; DIGESTIVE SYSTEM SURGICAL PROCEDURES; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL DISEASES; INTESTINAL MUCOSA; INTESTINES; MALNUTRITION; NUTRITIONAL SUPPORT; PEPTIDES; POSTOPERATIVE COMPLICATIONS; SHORT BOWEL SYNDROME;

EID: 84873623577     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607112472906     Document Type: Review

References (49)

1. National Digestive Diseases Information Clearinghouse. Short bowel syndrome. http://digestive.niddk.nih.gov/ddiseases/pubs/shortbowel/. Accessed October 11, 2012.
2. O'Keefe SJ, Buchman AL, Fishbein TM, Jeejeebhoy KN, Jeppesen PB, Shaffer J. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol. 2006 ; 4: 6-10 (Pubitemid 43129518)
3. Donohoe CL, Reynolds JV. Short bowel syndrome. Surgeon. 2010 ; 8: 270-279
4. Messing B, Crenn P, Beau P, Boutron-Ruault MC, Rambaud JC, Matuchansky C. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology. 1999 ; 117: 1043-1050 (Pubitemid 29512662)
5. Thompson JS, Weseman R, Rochling FA, Mercer DF. Current management of the short bowel syndrome. Surg Clin North Am. 2011 ; 91: 493-510
6. Jeejeebhoy KN. Short bowel syndrome: a nutritional and medical approach. CMAJ. 2002 ; 166: 1297-1302 (Pubitemid 34533954)
7. Hollwarth ME. Short bowel syndrome: pathophysiological and clinical aspects. Pathophysiology. 1999 ; 6: 1-19 (Pubitemid 29244153)
8. Matarese LE, Steiger E. Dietary and medical management of short bowel syndrome in adult patients. J Clin Gastroenterol. 2006 ; 40: S85 - S93
9. Buchman AL. Etiology and initial management of short bowel syndrome. Gastroenterology. 2006 ; 130: S5 - S15
10. DiBaise JK, Young RJ, Vanderhoof JA. Intestinal rehabilitation and the short bowel syndrome: part 2. Am J Gastroenterol. 2004 ; 99: 1823-1832 (Pubitemid 39237516)
11. Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O'Keefe SJ. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut. 2011 ; 60: 902-914
12. Jeppesen PB, Sanguinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut. 2005 ; 54: 1224-1231 (Pubitemid 41192479)
13. Jeppesen PB, Pertkiewicz M, Messing B, et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology. 2012 ; 143: 1473-1481
14. Estall JL, Drucker DJ. Glucagon-like peptide-2. Annu Rev Nutr. 2006 ; 26: 391-411
15. Scott RB, Kirk D, MacNaughton WK, Meddings JB. GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol. 1998 ; 275: G911 - G921
16. Tappenden KT, Edelman J, Joelsson B. Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome. J. Clin Gastroenterol. 2013 ;:
17. Jeejeebhoy KN. Management of short bowel syndrome: avoidance of total parenteral nutrition. Gastroenterology. 2006 ; 130: S60 - S66
18. Messing B, Joly F. Guidelines for management of home parenteral support in adult chronic intestinal failure patients. Gastroenterology. 2006 ; 130: S43 - S51
19. Carbonnel F, Cosnes J, Chevret S, et al. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr. 1996 ; 20: 275-280 (Pubitemid 26286192)
20. Weale AR, Edwards AG, Bailey M, Lear PA. Intestinal adaptation after massive intestinal resection. Postgrad Med J. 2005 ; 81: 178-184 (Pubitemid 40387967)
21. Tappenden KA. Mechanisms of enteral nutrient-enhanced intestinal adaptation. Gastroenterology. 2006 ; 130: S93 - S99
22. Feldman EJ, Dowling RH, McNaughton J, Peters TJ. Effects of oral versus intravenous nutrition on intestinal adaptation after small bowel resection in the dog. Gastroenterology. 1976 ; 70: 712-719
23. Ford WD, Boelhouwer RU, King WW, de Vries JE, Ross JS, Malt RA. Total parenteral nutrition inhibits intestinal adaptive hyperplasia in young rats: reversal by feeding. Surgery. 1984 ; 96: 527-534 (Pubitemid 14067501)
24. Seguy D, Vahedi K, Kapel N, Souberbielle JC, Messing B. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology. 2003 ; 124: 293-302 (Pubitemid 36169246)
25. Byrne TA, Wilmore DW, Iyer K, et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial. Ann Surg. 2005 ; 242: 655-661 (Pubitemid 41567120)
26. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002 ; 26: 1SA - 138SA
27. DiBaise JK Intestinal Failure: Diagnosis, Management and Transplantation. Langnas A Goulet O Quigley EM Tappenden KA, ed. Oxford, England: Blackwell ; 2008 :
28. American Gastroenterological Association medical position statement: short bowel syndrome and intestinal transplantation. Gastroenterology. 2003 ; 124: 1105-1110
29. MacMahon RA. The use of the World Health Organization's oral rehydration solution in patients on home parenteral nutrition. JPEN J Parenter Enteral Nutr. 1984 ; 8: 720-721 (Pubitemid 15207453)
30. Nordgaard I, Hansen BS, Mortensen PB. Colon as a digestive organ in patients with short bowel. Lancet. 1994 ; 343: 373-376 (Pubitemid 24049553)
31. Byrne TA, Veglia L, Camelio M, et al. Beyond the prescription: optimizing the diet of patients with short bowel syndrome. Nutr Clin Pract. 2000 ; 15: 306-311
32. Hofmann AF, Poley JR. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection, I: response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology. 1972 ; 62: 918-934
33. Thompson WG, Thompson GR. Effect of cholestyramine on the absorption of vitamin D3 and calcium. Gut. 1969 ; 10: 717-722
34. Parrish CR. The clinician's guide to short bowel syndrome. Pract Gastroenterol. 2005 ; 29: 67-106 (Pubitemid 41451924)
35. Ziegler TR, Cole CR. Small bowel bacterial overgrowth in adults: a potential contributor to intestinal failure. Curr Gastroenterol Rep. 2007 ; 9: 463-467 (Pubitemid 351795703)
36. Dube PE, Brubaker PL. Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators. Am J Physiol Endocrinol Metab. 2007 ; 293: E460 - E465
37. Drucker DJ, Erlich P, Asa SL, Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A. 1996 ; 93: 7911-7916 (Pubitemid 26277138)
38. Tsai CH, Hill M, Asa SL, Brubaker PL, Drucker DJ. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol Endocrinol Metab. 1997 ; 273: E77 - E84
39. Wojdemann M, Wettergren A, Hartmann B, Holst JJ. Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. Scand J Gastroenterol. 1998 ; 33: 828-832 (Pubitemid 28423636)
40. Wojdemann M, Wettergren A, Hartmann B, Hilsted L, Holst JJ. Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2. J Clin Endocrinol Metab. 1999 ; 84: 2513-2517
41. Tavares W, Drucker DJ, Brubaker PL. Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats. Am J Physiol Endocrinol Metab. 2000 ; 278: E134 - E139
42. Drucker DJ, Shi Q, Crivici A, et al. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV. Nat Biotechnol. 1997 ; 15: 673-677 (Pubitemid 27291170)
43. Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology. 2001 ; 120: 806-815 (Pubitemid 32193176)
44. Bremholm L, Hornum M, Henriksen BM, Larsen S, Holst JJ. Glucagon-like peptide-2 increases mesenteric blood flow in humans. Scand J Gastroenterol. 2009 ; 44: 314-319
45. Bremholm L, Hornum M, Andersen UB, Hartmann B, Holst JJ, Jeppesen PB. The effect of glucagon-like peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients. Regul Pept. 2011 ; 168: 32-38
46. Jeppesen PB, O'Keefe S, Chu H, Joelsson B. Short bowel syndrome patients with intestinal failure (SBS-IF) successfully achieved complete independence from parenteral nutrition and/or intravenous fluid (PN/IV) with teduglutide. Gastroenterology. 2012 ; 142: S369 - S370
47. Fujioka K, Jeppesen P, O'Keefe S, Chu H, Joelsson B, Berghoefer P. Long term therapy with teduglutide: characteristics of patients with short bowel syndrome who achieve complete independence from parenteral nutrition and/or intravenous fluid support. American Journal Gastroenterology. 2012 ; 107: S141
48. DiBaise JK, Matarese LE, Messing B, Steiger E. Strategies for parenteral nutrition weaning in adult patients with short bowel syndrome. J Clin Gastroenterol. 2006 ; 40: S94 - S98
49. Joly F, Dray X, Corcos O, Barbot L, Kapel N, Messing B. Tube feeding improves intestinal absorption in short bowel syndrome patients. Gastroenterology. 2009 ; 136: 824-831